Skip to content
healthcare.dev
Get a free key

Ranitidine

NDC 53746-254, Ranitidine, tablet, from Amneal Pharmaceuticals of New York LLC.

Product NDC
53746-254
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077824
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53746-254 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RANITIDINE HYDROCHLORIDE300 mg/1

Pharmacologic classes

Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]

Package NDCNDC-11Package
53746-254-0153746025401100 TABLET in 1 BOTTLE (53746-254-01)
53746-254-0253746025402250 TABLET in 1 BOTTLE (53746-254-02)
53746-254-305374602543030 TABLET in 1 BOTTLE (53746-254-30)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b38a3332-5c54-453f-aeb7-070f830955c2

Use it

Look up 53746-254 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53746-254 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53746-254. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.